Procter & Gamble (NYSE:PG) Price Target Increased to $182.00 by Analysts at Jefferies Financial Group

Procter & Gamble (NYSE:PG) had its target price hoisted by Jefferies Financial Group from $175.00 to $182.00 in a research report issued on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price objective indicates a potential upside of 15.09% from the company’s previous close.

PG has been the subject of several other reports. Barclays lifted their target price on shares of Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a research report on Friday, April 12th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Procter & Gamble from $170.00 to $172.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a research note on Friday, March 1st. They set a “neutral” rating and a $168.00 price target on the stock. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. Finally, UBS Group lifted their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $168.82.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $158.14 on Monday. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $372.11 billion, a PE ratio of 25.84, a P/E/G ratio of 3.19 and a beta of 0.44. Procter & Gamble has a twelve month low of $141.45 and a twelve month high of $163.14. The company has a 50-day moving average price of $159.14 and a two-hundred day moving average price of $153.02.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.77%. The company had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same period last year, the business earned $1.37 earnings per share. Procter & Gamble’s revenue was up .6% compared to the same quarter last year. Equities analysts forecast that Procter & Gamble will post 6.53 EPS for the current year.

Insiders Place Their Bets

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 74,443 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total value of $11,412,111.90. Following the completion of the transaction, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $149,160.90. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, insider Marc S. Pritchard sold 101,704 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the completion of the sale, the insider now owns 163,428 shares of the company’s stock, valued at approximately $25,097,637.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Ma. Fatima Francisco sold 74,443 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the sale, the chief executive officer now directly owns 973 shares of the company’s stock, valued at approximately $149,160.90. The disclosure for this sale can be found here. In the last 90 days, insiders sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is owned by insiders.

Institutional Investors Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently made changes to their positions in the business. Axiom Financial Strategies LLC raised its stake in Procter & Gamble by 7.0% during the 1st quarter. Axiom Financial Strategies LLC now owns 1,728 shares of the company’s stock worth $276,000 after acquiring an additional 113 shares during the period. AMI Investment Management Inc. grew its holdings in Procter & Gamble by 7.2% during the 1st quarter. AMI Investment Management Inc. now owns 3,461 shares of the company’s stock valued at $529,000 after buying an additional 233 shares in the last quarter. LSV Asset Management grew its holdings in Procter & Gamble by 5.7% during the 1st quarter. LSV Asset Management now owns 18,600 shares of the company’s stock valued at $2,842,000 after buying an additional 1,000 shares in the last quarter. Ergoteles LLC purchased a new stake in Procter & Gamble during the 1st quarter valued at approximately $3,073,000. Finally, Wsfs Capital Management LLC grew its holdings in Procter & Gamble by 12.0% during the 1st quarter. Wsfs Capital Management LLC now owns 4,256 shares of the company’s stock valued at $650,000 after buying an additional 455 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.